Home > Healthcare > Biotechnology > Biotechnology R&D > Cloning and Mutagenesis Market

Cloning and Mutagenesis Market Trends

Report ID: GMI6030
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Cloning and Mutagenesis Market Trends

Cloning and mutagenesis plays a significant role in precision medicine by facilitating the development of customized therapies. Cloning and mutagenesis techniques allow researchers to produce recombinant proteins, antibodies, or cellular models that aid in the discovery and development of precision drugs. Therefore, the demand for precision medicine has accelerated the adoption and advancement of cloning and mutagenesis technologies. Further, these tools are instrumental in understanding the genetic basis of diseases, developing targeted therapies, and optimizing treatment outcomes for individual patients.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cloning and mutagenesis was USD 2.9 billion in 2023 and is likely to expand at 19.4% CAGR from 2024 to 2032 driven by the growing focus on genetic engineering and rising demand for genetically modified products.

The cloning kits product segment held more than 53% of the Cloning and mutagenesis market share in 2022 and is expected to witness high demand for various applications in gene cloning, protein expression, genetic engineering, and DNA sequencing among others.

North America held over 38.6% of the cloning and mutagenesis industry share in 2022 and is estimated to expand further through 2032 owing to the presence of key market players in the region.

Few top firms engaged in the global market are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Takara Bio Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, New England Biolabs, Promega Corporation, and Assay Genie